Evidence map›Paper›PMID 38563494›Full record

ArticleAdvanced healthcare materials2024

LiFT (a Lithium Fiber-Based Test): An At-Home Companion Diagnostics for a Safer Lithium Therapy in Bipolar Disorder.

Farbod Amirghasemi, Sina Khazaee Nejad, Ruitong Chen, Ali Soleimani, Victor Ong, Nika Shroff, Tanya Eftekhari, Kara Ushijima, Alar Ainla, Steven Siegel and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced healthcare materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. A Geometrically Transient Platform for Bioelectronic Implants.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Farbod AmirghasemiAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.
Sina Khazaee NejadAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.
Ruitong ChenAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.
Ali SoleimaniAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.
Victor OngAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.
Nika ShroffAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.
Tanya EftekhariKern Medical Center, 1700 Mount Vernon Ave, Bakersfield, CA, 93306, USA.
Kara UshijimaAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.
Alar AinlaInternational Iberian Nanotechnology Laboratory, Braga, 4715-330, Portugal.
Steven SiegelDepartment of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.
Maral P S MousaviAlfred E. Mann Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA.ORCID 0000-0003-0004-7178
University of Southern California · USInternational Iberian Nanotechnology Laboratory · PTKern Medical Center · US

Funding

Building a two-way communication system: Bio-orthogonal superhydrophobic nanoparticles for controlled stimulation and real-time sensing of neurotransmittersDP2GM150018 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MOUSAVI, MARAL · 2022 to 2025
$2.3M
NIGMS NIH HHS DP2 GM150018NIGMS NIH HHS DP2GM150018
6 · The paper itself

Abstract

This work presents LiFT (a lithium fiber-based test), a low-cost electrochemical sensor that can measure lithium in human saliva and urine with FDA-required accuracy. Lithium is used for the treatment of bipolar disorder, and has a narrow therapeutic window. Close monitoring of lithium concentration in biofluids and adjustment of drug dosage can minimize the devastating side effects. LiFT is an inexpensive, yet accurate and simple-to-operate lithium sensor for frequent at-home testing for early identification of lithium toxicity. The low cost and high accuracy of LiFT are enabled through an innovative design and the use of ubiquitous materials such as yarn and carbon black for fabrication. LiFT measures Li

Indexed as

Bipolar DisorderElectrochemical TechniquesLithiumDrug MonitoringPoint-of-Care TestingSalivaUrineLithiumaffordable medical testingbipolar disordercompanion diagnosticslithium therapymobile healthpoint‐of‐care sensorpotentiometric sensing

Identifiers

PMID38563494
PMCPMC11466011
OpenAlexW4393410316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.